Article
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
24 Nov 2010
Abstract excerpt
Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei. Eflornithine is used as a first line treatment for human African trypanosomiasis, but there is a risk that resistance could thwart its use, even when used in combination therapy with nifurtimox. Eflornithine resistant trypanosomes were selected in vitro...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
